Pure Em Life Science India Private Limited, a active private limited company, was established on 24 July 2019 in Ernakulam, Kerala, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U33309KL2019PTC058947. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.15 M.
It upholds a compliant status. Its leadership includes Geemon Kadianthuruthil Korah (Director), Fazil Salam (Managing Director), Sam Babu (Director). Past directors included Suja Babu, Babu Samuel Chetticheril, Daya Elsa Jacob. It holds ₹2.15 Cr open charges and ₹4.50 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 65/244, Kasim Lane, Ernakulam, Kerala, 682018.
U33309KL2019PTC058947
058947
24 July 2019
₹1.00 M
₹0.15 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Pure Em Life Science India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Geemon Kadianthuruthil Korah | Director | 01 Apr 2022 | Current |
| Fazil Salam | Managing Director | 24 Jul 2019 | Current |
| Sam Babu | Director | 24 Jul 2019 | Current |
| Joe Paul Mampilly | Director | 01 Apr 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 15 Oct 2020 | Past |
| Pramod Abcsdd | Director | 15 Oct 2020 | Past |
| Pramod Abcsdd | Director | 15 Oct 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Pure Em Life Science India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 84.73% increase. The company also saw a substantial improvement in profitability, with a 81.79% increase in profit. The company's net worth Soared by an impressive increase of 252.14%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Pure Em Life Science India had a public holding of 33.34%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹21,500,000.00
₹4,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 May 2024 | Others | ₹2.00 Cr | Open |
| 01 Aug 2023 | Hdfc Bank Limited | ₹1.50 M | Open |
| 28 Dec 2023 | Hdfc Bank Limited | ₹4.50 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Pure Em Life Science India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Pure Em Life Science India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pure Em Life Science India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Others of Rs. 20.00 M registered on 18 May 2024 with Charge ID 100933261 was modified on 28 Apr 2025. was completed.
The activity Pure Em Life Science India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on A charge registered on 28 Dec 2023 via Charge ID 100881776 with Hdfc Bank Limited was fully satisfied on 01 Jun 2024. was documented.
A charge with Others amounted to Rs. 20.00 M with Charge ID 100933261 was registered on 18 May 2024. was recorded as a recent event.
The activity Pure Em Life Science India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 4.50 M with Charge ID 100881776 was registered on 28 Dec 2023. was completed.
The CIN of Pure Em Life Science India Private Limited is U33309KL2019PTC058947.
Pure Em Life Science India Private Limited is headquartered at 65/244, Kasim Lane, Ernakulam, Kerala, 682018.
Pure Em Life Science India Private Limited was incorporated on 24 July 2019.
The current directors of Pure Em Life Science India Private Limited are
The primary industry of Pure Em Life Science India Private Limited is Trade.
Pure Em Life Science India Private Limited is unlisted.
The authorized capital of Pure Em Life Science India Private Limited is ₹1.00 M, and the paid-up capital is ₹0.15 M.
The compliance status of Pure Em Life Science India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX